TheProfitWatch

GALT - Galectin Therapeutics Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
5.75 -0.43 (-7.48%) --- -0.01 (-0.19%) -0.01 (-0.19%) 0.01 (0.17%) -0.35 (-6.17%) 0.0 (0.0%) 0.0 (0.0%)

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.12
Diluted EPS:
-0.12
Basic P/E:
-44.3333
Diluted P/E:
-44.3333
RSI(14) 1m:
62.3
VWAP:
5.32
RVol:

Events

Period Kind Movement Occurred At

Related News